![Lab Owner Pleads Guilty to $89 Million Fraud Scheme](https://www.g2intelligence.com/wp-content/uploads/2023/03/March29-2023.News_.WeeklyEnforcementReport.CGxFraud-iStock-1270526955-1800x1250-1-1080x675.jpg)
Lab Owner Pleads Guilty to $89 Million Fraud Scheme
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.
As we move further into 2023, COVID-19, add-on, and genetic tests will likely remain targets for federal regulators.